• 2022-06
  • 2022-05
  • 2022-04
  • 2021-03
  • 2020-08
  • 2020-07
  • 2020-03
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • br Methods br Patients and Settings


    Patients and Settings
    This analysis is part of a longitudinal study, funded by the National Cancer Institute, that evaluated for neuro-pathic pain and lymphedema in a sample of women who underwent breast cancer surgery. The methods used are described in detail elsewhere.39,42 In brief, patients were recruited from breast care centers located in a 
    Genetic Associations With Persistent Arm Pain
    comprehensive cancer center, 2 public hospitals, and 4 AR-13324 practices. Patients were eligible to participate if they were an adult woman (≥18 years) who would undergo breast cancer surgery on 1 breast; were able to read, write, and understand English; agreed to partici-pate; and gave written informed consent. Patients were excluded if they were having breast cancer surgery on both breasts and/or were known to have distant metasta-sis at the time of diagnosis. A total of 516 patients were approached and 410 enrolled in the study. For this analy-sis, 398 women completed study questionnaires and 310 provided blood samples for genetic analyses.
    A demographic questionnaire obtained information on age, education, ethnicity, marital status, employ-ment status, living situation, and financial status. The Karnofsky Performance Status (KPS) scale was used to evaluate patients’ functional status.26,27 The Self-Administered Comorbidity Questionnaire was used to
    evaluate the occurrence of, treatment for, and impact of 13 common medical conditions.10,11,37,56,59 Patients
    were asked to indicate if they exercised on a regular basis (yes/no format).
    Upper extremity pain was evaluated using the Arm/ Shoulder Symptoms Questionnaire and Postsurgical Pain Questionnaire. The Arm/Shoulder Symptoms Ques-tionnaire consisted of 2 parts. Part 1 obtained informa-tion on the occurrence of pain in the arm and shoulder area. If the patient had pain in the shoulder, arm, or hand, they completed part 2. Patients were asked to rate the intensity of their average and worst pain using a numeric rating scale that ranged from 0 (no pain) to 10 (worst imaginable pain).25 The Arm/Shoulder Symp-toms Questionnaire was completed monthly for 6 months after surgery. The Postsurgical Pain Question-naire evaluated pain intensity in the first 24 to 48 hours after surgery. Average and worst pain were rated using a 0 (no pain) to 10 (worst imaginable pain) numeric rat-ing scale. This Post-Surgical Pain Questionnaire was completed once during the month 1 study visit.
    Study Procedures
    The study was approved by the Committee on Human Research at the University of California, San Francisco, and by the institutional review boards at each of the study sites. During the patient’s preoperative visit, a cli-nician explained the study to the patient and deter-mined her willingness to participate. For those women who were willing to participate, the clinician introduced the patient to a research nurse. The research nurse met with the women, determined eligibility, and obtained written informed consent before surgery. After obtain-ing the consent, patients completed the enrollment questionnaires (assessment 0).
    Patients were contacted 2 weeks after surgery to sched-ule the first postsurgical appointment. The research nurse met with the patients either in their home or in the clinical research center at 1, 2, 3, 4, 5, and 6 months after surgery.
    Knisely et al
    During each of the study visits, the women completed the study questionnaires and provided information on new and ongoing treatments. Over the course of the study, patients’ medical records were reviewed for disease and treatment information.
    Characterization of the Persistent Arm Pain Phenotype
    Characterization of the arm pain phenotype was described previously.43 In summary, GMM with robust maximum likelihood estimation was carried out to iden-tify latent classes of patients with distinct persistent arm pain trajectories. Arm/shoulder pain scores were assessed monthly for 6 months after breast cancer sur-gery. Patients who reported no pain in their affected arm/shoulder for all 6 assessments (n = 164 [41.6%]) were not included in the GMM analysis. These women comprised the no pain group for the current analyses. For the remaining 230 women, 6 ratings of worst arm/ shoulder pain were used in the GMM analysis to assign each patient into a latent class. The GMM analysis was performed using Mplus 6.1.45